- Prelims Test Series (PTS) for Prelims 2027 starts 11th Oct. 2026 Click Here to know more →
- Ethics Redbook 3rd Edition: A Textbook That Teaches You How to Think Ethically Click Here to Read More →
- 21 Sept. | Forum Residential Coaching (FRC) for UPSC preparation Click Here to know more →
- 21 Sept. | GS Advance Program (GSAP) for UPSC 2027 Mains starts from 10th Oct. Click Here to Read More →
Source: The post is based on the article “Union Minister launches the GEMCOVAC® -OM, an Omicron-specific mRNA-based Booster vaccine” published in PIB on 23rd June 2023
What is the News?
The Union Minister of Science and Technology has launched GEMCOVAC® -OM, an Omicron-specific mRNA-based Booster vaccine.
What is GEMCOVAC-OM?
GEMCOVAC-OM is an indigenously developed mRNA vaccine against the dominant Omicron variant of the COVID-19 coronavirus.
It is India’s first mRNA vaccine.
Developed by: Pune based Gennova Biopharmaceuticals with funding support from the Department of Biotechnology (DBT) and Biotechnology Industry Research Assistance Council (BIRAC).
Features: It is a thermostable vaccine and does not require ultra-cold chain infrastructure used for other approved mRNA-based vaccines.
– It is delivered intra-dermally using a needle-free injection device system.
– It will for now only be available as a booster or “precaution dose”.
